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The persistence of infectious biomolecules in soil constitutes a substantial challenge. This holds particularly true with respect
to prions, the causative agents of transmissible spongiform encephalopathies (TSEs) such as scrapie, bovine spongiform
encephalopathy (BSE), or chronic wasting disease (CWD). Various studies have indicated that prions are able to persist in soil
for years without losing their pathogenic activity. Dissemination of prions into the environment can occur from several
sources, e.g., infectious placenta or amniotic fluid of sheep. Furthermore, environmental contamination by saliva, excrements
or non-sterilized agricultural organic fertilizer is conceivable. Natural transmission of scrapie in the field seems to occur via the
alimentary tract in the majority of cases, and scrapie-free sheep flocks can become infected on pastures where outbreaks of
scrapie had been observed before. These findings point to a sustained contagion in the environment, and notably the soil. By
using outdoor lysimeters, we simulated a contamination of standard soil with hamster-adapted 263K scrapie prions, and
analyzed the presence and biological activity of the soil-associated PrP
Sc and infectivity by Western blotting and hamster
bioassay, respectively. Our results showed that 263K scrapie agent can persist in soil at least over 29 months. Strikingly, not
only the contaminated soil itself retained high levels of infectivity, as evidenced by oral administration to Syrian hamsters, but
also feeding of aqueous soil extracts was able to induce disease in the reporter animals. We could also demonstrate that PrP
Sc
in soil, extracted after 21 months, provides a catalytically active seed in the protein misfolding cyclic amplification (PMCA)
reaction. PMCA opens therefore a perspective for considerably improving the detectability of prions in soil samples from the
field.
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INTRODUCTION
Transmissible spongiform encephalopathies (TSEs) comprise
a group of fatal neurodegenerative diseases such as bovine
spongiform encephalopathy (BSE) in cows [1], chronic wasting
disease (CWD) in deer (Odocoileus spp.) and elk (Cervus elaphus nelsoni)
[2–4], scrapie in sheep and goats [5–7] and Creutzfeldt-Jakob
disease (CJD) in humans [1]. The exact molecular pathomechan-
isms underlying TSEs have not yet been fully elucidated but it is
generally accepted that a pathologically misfolded and/or
aggregated isoform of the normal cellular prion protein (PrP),
referred to as PrP
Sc and PrP
C, respectively, is the key pathogenic
factor for this group of diseases [1].
Among the known TSEs, only scrapie and CWD are contagious
diseases which show horizontal transmissibility under natural
conditions [2,4,8]. CWD is the only TSE known to affect free-
ranging animals [3]. The regular occurrence of scrapie in affected
areas [7] and the spread of CWD in North America and Korea
[9,10] among mule deer, white-tailed deer and elk indicates that
a contagion in the environment is responsible for the occurrence of
these TSEs [4,11–14], and even raises the possibility of a cross-
species transmission under natural conditions. Recent findings
demonstrated that saliva from deer with CWD harbours infectivity
and can transmit this TSE upon peroral uptake [15]. Other studies
pointed to transmission of scrapie among sheep by vectors like
mites, fly larvae or other ectoparasites [16–19]. It has also been
hypothesized that sporadically occurring TSEs may be induced by
insecticides or by a disproportion of manganese and copper in soil
leading to an enrichment of manganese in animals [20,21].
Alternatively, an influence of the Fe/Mn ratio in forage has been
discussed in connection with TSEs [22]. However, on the balance
of all evidence available so far, contaminated soil appears as one of
the most likely sources of infection in the natural transmission of
scrapie and possibly also CWD. It has been known for decades
that sheep can become infected with scrapie while grazing on
pastures where infected sheep have been kept before, and scrapie
occurs often in areas where it has already occurred previously
[7,8,23]. Furthermore, Brown and Gajdusek found that scrapie
agent remains infectious after persisting in soil for 3 years as
evidenced by intracerebral bioassay in Syrian hamsters [24]. The
putative transmission of scrapie and CWD via soil is also
corroborated by recent studies showing that prion infectivity
binds to soil components with high affinity [25,26], thereby
retaining its pathogenic biological activity [25]. Thus, soil-
associated TSE agents in the environment represent a potential
hazard. This holds true not least since prion infectivity exhibits an
unusually pronounced resistance against both physical and
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PLoS ONE | www.plosone.org 1 May 2007 | Issue 5 | e435chemical methods of inactivation, as described in detail elsewhere
[27–37].
The contamination of soil with TSE infectivity can occur from
several sources. Since recent studies could demonstrate that
scrapie infectivity is present in various tissues and body fluids of
infected animals [38,39], it has been assumed that the persistent
prion protein enters the environment by contaminated excre-
ments, birth-related tissues such as placenta, or even whole
carcasses. While a similar excretion pattern appears conceivable
for the CWD agent [40] which has also been found in saliva [15],
the present knowledge about the BSE pathology in cattle does not
argue for a significant shedding of the infectivity via faeces, urine,
or during birth [41,42]. However, small ruminants infected with
BSE could supposedly spread the BSE agent throughout the
environment in a similar manner as known from scrapie-affected
sheep or CWD-affected animals [43]. Moreover, unconventional
conditions like for example the burial of animal carcasses at larger
numbers as practiced for example during the foot and mouth
disease outbreak in the UK in 2001 [44], may have fostered
a dissemination of BSE agent in the soil or ground water. Once
deposited there, all three TSE agents, BSE, scrapie, and CWD,
must be assumed to persist in an infectious state for long periods of
time.
So far, the oral transmission efficacy of long-term prion
contaminations in soil have not been investigated. Therefore, we
have studied the persistence of PrP
Sc in the environment over time
and measured its oral transmissibility by bioassay in Syrian
hamsters. With outdoor lysimeter experiments we simulated the
situation on pastures using soil spiked with scrapie-infected
hamster brain homogenate over a period of 29 months and
analyzed the fate of the prion proteins by sensitive Western
blotting and, in part, also by protein misfolding cyclic amplifica-
tion (PMCA). The infectivity of such contaminated soil samples
and the respective aqueous soil extracts was tested in the hamster
bioassay.
RESULTS
Extraction and Recovery
In the first phase of the study several buffers – known as standard
buffers for protein extraction from mammalian cells – and other
solutions were tested in order to find out the optimal extraction
method for prion protein from contaminated soil (see Materials
and Methods). The obtained results lead us to use 1% SDS
(sodium dodecyl sulphate) in sterilized water (figure 1a), which
allowed detection of PrP
Sc in samples of German standard soil
containing an amount of PrP
Sc that corresponded to 1.25 mgo f
infectious brain material (figure 1b).
Soil Incubation Experiments
The findings from our lysimeter experiments indicated a remark-
able persistence of PrP
Sc in soil by clearly showing that - even after
an incubation for 29 months - PrP
Sc could be still extracted from
soil and detected by Western blotting. These results were
confirmed by using two alternative highly sensitive Western
blotting techniques. As shown in figure 2a, PrP
Sc, in the form of its
protease-resistant core of the pathological prion protein PrP
Sc
(PrP27-30), is still detectable in soil after 29 months. However,
a decrease in the extractable concentration is obvious. The
strongest decrease can be seen during the first month of incubation
in the soil (figure 2a, lane 2 and 3). After three months the
extractable amount of PrP27-30 remained almost constant until
month 21, with small variations at month 12 and month 18
(figure 2a, lane 6 and 7). In Fig. 2a, a slightly stronger signal for
PrP27-30 was found for 21 months (lane 8) as compared to
18 months (lane 7). Both samples were taken from the same soil
bag, however, the location from where the sampling was
performed may have differed. Thus, the finding possibly reflects
minor inhomogenities either in the original load of contamination
or in the degradation of PrP
Sc depending on the microenviron-
ment of the examined sample. On the other hand, it has to be
noted that the extraction yield and Western blotting efficiency
inevitably may also vary in certain ranges from sample to sample.
A further decrease was observed after 26 and 29 months (figure 1a,
lane 9 and 10), however, the PrP27-30 specific bands remain
clearly visible. Where performed, analyses of samples from
different soil bags produced consistent results. In order to verify
that the detected bands originated from PrP
Sc a control experi-
ment was performed: After deglycosylation with PNGase F the
PrP27-30 bands extracted from soil after 21 and 18 month showed
an electrophoretic shift towards a single band at about 20 kDa, the
molecular mass to be expected for deglycosylated PrP27-30 from
263K hamster scrapie (figures 2 b, lanes 3 and 4, respectively).
Amplification of PrP
Sc extracted from soil
In order to check whether PrP
Sc extracted from soil can be used
for the amplification of protease resistant prion protein by the
protein misfolding cyclic amplification (PMCA) reaction [45,46],
soil extracts from month 21 were used as test seeds. As shown in
figure 2c, a strong increase of the signal for PrP
Sc was obtained
with this method: while no signal for PrP
Sc can be detected in
Figure 1. Western blot analysis of short-time incubation experiments.
a) Western blot detection of PrP
C extracted from soil mixed with non-
infectious brain homogenate (5% pork brain in German standard soil).
Several different buffers and solutions were used for extraction. Lane 1:
water; lane 2: Triton X-100; lane 3: 1% urea; lane 4: 1% SDS; lane 5:
Zwittergent; lane 6: RIPA buffer; lane 7: NP-40; lane 8: Na-sarcosyl. b)
Western blot detection of PrP27-30, the proteinase K-resistant core of
PrP
Sc, extracted by using 1% SDS from soil contaminated with 263 K
scrapie brain homogenate from hamsters after 1 h of incubation
(dilution series). PrP
Sc could be detected in soil samples containing
1.25 mg or higher amounts of scrapie brain tissue after extraction with
1% SDS-solution. Samples were digested with proteinase K prior to
Western blotting.
doi:10.1371/journal.pone.0000435.g001
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visible after 40 cycles of PMCA (lane 3) and even more intense
after 80, 120 and 160 cycles of PMCA (lanes 4, 5 and 6,
respectively).
Presence of PrP
Sc in surrounding soil samples
For analyzing the fate of the prion protein in more detail, soil
samples in the vicinity of the gauze bag, as well as the gauze bag
itself were analyzed by Western blotting. As shown in figure 3a, no
PrP
Sc specific signal could be detected in the surrounding soil
samples. This is indicative of PrP
Sc being immobilized after
binding to soil compartments. In some approaches, a very faint
PrP
Sc specific signal was visible when analyzing aliquots of SDS
solution in which the gauze bag had been washed, however, it
could be shown that this positive prion signal was a result of
adherent soil particles (figure 3, lane 3, arrow).
Bioassay Experiments
For a detailed risk assessment of scrapie-contaminated soil it was of
major importance to analyze whether the detectable PrP
Sc in the
soil extracts still exhibited oral infectivity after incubation times up
to 29 months. Therefore, a bioassay with Syrian hamsters was
performed by feeding the animals with contaminated soil or
aqueous soil extracts that had been collected after soil incubation
for 26 and 29 months, respectively. Hamsters fed with contam-
inated soil exhibited first scrapie-associated symptoms at
13166 days [mean6SD] after the first application. The hamsters
reached the terminal stage of scrapie at 162612 days after the first
feeding (tables 1 & 2). This indicates substantial amounts of
persistent infectivity in soil that had been incubated for 26 and
29 months. After reaching the terminal stage of scrapie the
animals were sacrificed and analyzed for the presence of PrP
Sc in
their brains. As shown in figure 4a (lanes 2 and 3 depicting two
hamsters exemplarily), the brains of all animals in this group
contained high amounts of PrP
Sc. In addition, comparison of the
electrophoretic and glycosylation profiles of the brain samples
from these hamsters (figure 4b, lanes 4 and 5) with those of
hamsters challenged with different TSE isolates (figure 4b, ME7-
H, lane 1; BSE-H, lane 2, 263K, lane 3) confirmed, that strain
specific biochemical properties of the pathological prion protein
Figure 2. Western blot analysis of long-time incubation experiments. a) Western blot detection of PrP27-30 extracted from prion-contaminated soil
after different time periods. Lane 1: PK-digested 263K scrapie hamster brain homogenate containing 5610
27 g of brain tissue (positive control); lanes
2–10: PrP27-30 extracted at time point 0 (lane 2), after 1 month (lane 3), after 3 months (lane 4), after 6 months (lane 5), after 12 months (lane 6), after
18 months (lane 7), after 21 months (lane 8), after 26 months (lane 9) and after 29 months (lane 10). b) Deglycosylated PrP27-30 extracted from prion
contaminated soil. Lane 1: PK-digested 263K scrapie hamster brain homogenate containing 5610
27 g of brain tissue (positive control); lane 2: soil-
extracted PrP27-30 after 21 months; lanes 3 and 4: deglycosylated soil-extracted PrP27-30 after 21 months (lane 3) and after 18 months (lane 4). c)
PMCA amplification of PrP
Sc extracted from contaminated soil. Lane 1: PK-digested 263K scrapie hamster brain homogenate containing 5610
27 go f
brain tissue (positive control); lanes 2–6: sample signals after 0, 40, 80, 120 and 160 cycles of PMCA, respectively.
doi:10.1371/journal.pone.0000435.g002
Figure 3. Western blot detection of PrP27-30 extracted from prion-
contaminated soil after 21 months (M21) and respective surrounding
samples. M21: contaminated soil sample inside the gauze bag; lane 1:
soil sample collected outside of the steel cage; lane 2: soil sample
collected directly over the gauze bag; lane 3: analysis of the empty
gauze bag; lane 4: soil sample collected underneath the steel cage; lane
5: soil sample collected directly next to the gauze bag; lane 6: roots
collected next to the gauze bag; lane 7: soil sample collected
underneath the gauze bag; lane 8: non-contaminated soil. Arrow head
at lane 3 indicates a faint PrP27-30 signal, resulting from residual soil
particles that remained attached to the gauze bag.
doi:10.1371/journal.pone.0000435.g003
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incubated with 263K scrapie brain homogenate.
Remarkably, not only the hamsters fed with contaminated soil
but also four hamsters of the group fed with aqueous soil extracts
developed terminal scrapie at 256641 days after the first
application (with incubation times of individual animals ranging
from 201 to 321 days). Since this bioassay is ongoing, further
animals of this group might still develop scrapie in the future.
DISCUSSION
The results of this research project show for the first time that the
scrapie strain 263K remains persistent in soil over a period of at
least 29 months and remains highly infectious after oral applica-
tion to Syrian hamsters. It has to be pointed out that the key results
of our time-course study on the fate of PrP
Sc in soil have been
validated, in part by examining blinded samples, at independent
laboratories.
Only a few studies have addressed the question of a persistence
of prions in soil so far [24–26,47], and the results from these
studies are in principle in accordance with our observations. A
pioneering study was published by Brown and Gajdusek in 1991
[24] showing that an aqueous extract from scrapie-contaminated
soil remains infectious even after an incubation period of three
years as confirmed by hamster bioassay. However, the infectivity
studies were conducted by intracerebral injection and not by oral
application. Furthermore, the PrP
Sc concentration was not
analyzed in this study, so that no data are available about the
proteins absorption behavior to soil particles and about the
corresponding degradation kinetics. Most recently, PrP
Sc has been
shown to bind to soil minerals [25] but only short-time incubation
experiments of maximal one week were conducted and, again,
bioassays were performed by the intracerebral route.
In this study we show by Western blotting a strong decrease in
the amount of extractable PrP
Sc over an incubation period of
29 months in soil. It is not yet clear whether this decrease resulted
from a molecular degradation of PrP
Sc or a tighter binding to soil
particles. Stronger binding of molecules to soil particles with
increasing incubation time is a well-known phenomenon in soil
chemistry – the so called ‘‘aging’’ – and influences bioavailability
and re-mobilization significantly [48,49].
Upon feeding hamsters with scrapie contaminated soil which
had been incubated for over two years in outdoor lysimeters all
animals developed terminal scrapie after relatively short in-
Table 1. Feeding schedule for bioassay in Syrian hamsters
......................................................................
Date
amount of soil or aqueous
extract administered orally*
Collection time
of soil sample
31/01/06 100 mg or 100 ml month 26
07/02/06 100 mg or 100 ml month 26
14/02/06 100 mg or 100 ml month 26
21/02/06 100 mg or 100 ml month 26
28/02/06 100 mg or 100 ml month 26
08/03/06 100 mg or 100 ml month 26
14/03/06 100 mg or 100 ml month 26
21/03/06 50 mg or 50 ml month 26
28/03/06 100 mg or 100 ml month 29
06/04/06 100 mg or 100 ml month 29
11/04/06 100 mg or 100 ml month 29
20/04/06 100 mg or 100 ml month 29
*mg relates to soil sample; ml relates to aqueous extract
doi:10.1371/journal.pone.0000435.t001
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Table 2. Infection rate in hamster after oral challenge
......................................................................
Group
No. of animals
infected with
scrapie
Terminal stage of scrapie
after the first oral
application/Mean
incubation period with
the respective standard
deviation in days
Control 0/5* –
Control soil 0/5* –
Control aqueous extract 0/5* –
Contaminated soil 12/12 162 +/2 12
Contaminated aqueous soil
extract
4/11* 256 +/2 41
*In the marked groups one animal each died at the beginning of the bioassay
because of digestive disorders unrelated to scrapie disease
doi:10.1371/journal.pone.0000435.t002
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Figure 4. Western blot analysis of hamsters orally challenged with contaminated soil and western blot typing of PrP27-30. a) Western blot
showing PrP
Sc in the brains of hamster orally challenged with contaminated soil samples and in the soil samples used for the bioassay. Lane 1:
negative control hamster; lane 2: hamster H19 fed 12 times with aqueous extracts of soil samples from month 26 and 29; lane 3: hamster H4B fed 12
times with soil samples from month 26 and 29; lane 4: scrapie-contaminated soil (18 months); lane 5: scrapie-contaminated soil (21 months); lane 6:
negative soil sample. b) Western blot typing of electrophoretic mobilities and glycosylation characteristics of PrP27-30 from different hamster-
adapted TSE reference isolates, and from hamsters perorally challenged with 263K scrapie-contaminated soil. Lane 1: ME7-H scrapie agent; lane 2:
hamster-adapted BSE-isolate (BSE-H); lane 3: 263K scrapie agent, lane 4: H10 (hamster 10, fed 12 times with soil samples from months 26 and 29); lane
5: H7 (hamster 7 fed 12 times with soil samples from month 26 and 29).
doi:10.1371/journal.pone.0000435.g004
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established that pure 10% (w/v) brain homogenates from 263K
scrapie hamsters cause terminal scrapie in perorally challenged
hamsters after mean incubation times of about 155–165 days with
an attack rate of 100% [50–53]. This indicates that scrapie-
contaminated soil may represent a potential TSE hazard for
ruminants in the environment. While a considerable excretion of
infectivity has to be assumed for scrapie or BSE infected sheep and
CWD infected deer [40,43,54], it is generally acknowledged that
the potential environmental contamination risk represented by
BSE infected cattle is marginal, if at all present [41,42]. On the
other hand, the burial of bovine carcasses [44] might have
accidentally led to a spill of BSE prions into the environment.
Furthermore, the fact that even feeding of aqueous extracts from
scrapie-contaminated soil induced a terminal scrapie infection in
four hamsters so far suggests that surface water or groundwater
from pastures of scrapie-affected flocks may provide a potential
source of scrapie infectivity.
However, the relevance of the results obtained in this study for
the field situation should be interpreted with some caution, since
only one soil type was used and only a limited number of animals
were challenged in the bioassay. Therefore, other soil types and
a larger number of animals have to be tested in future studies to
allow for a robust risk assessment. Furthermore the exact binding
properties and degradation kinetics of PrP
Sc should be subject to
further research. In addition, all published studies addressing the
persistence of prion infectivity in soil were performed with scrapie
prions while TSE agents causing BSE and especially CWD have
not been analyzed so far.
An intensified monitoring of PrP
Sc (and possibly also prion
infectivity) in the soil appears mandatory for a more precise
assessment of the risks emanating for humans and animals from
prions in the environment. As shown in this report, PrP
Sc
extracted from soil can be used as a catalytically active seed in
the protein misfolding cyclic amplification (PMCA) reaction. This
opens a promising perspective for considerably improving the
detectability of prions in the environment.
MATERIALS AND METHODS
Biological Safety
Assays with scrapie-infected hamster brain were performed under
laboratory conditions according to bio safety level 3** and in
protected outdoor lysimeters, respectively.
Extraction of Brain Material
To identify a suitable buffer for extracting prion infectivity and
PrP
Sc from soil, German standard soil (Lufa 2.2 and Borstel) was
mixed with scrapie-infected hamster brain (strain 263K) provided
by the TSE-Resource-Centre, Berkshire, Great Britain. To test the
efficiency of this method the following solutions and buffers -
especially non-ionic and ionic detergents - have been tested:
a) sterile water, b) 1% urea in sterile water c) 1% SDS in sterile
water, d) 1% Zwittergent 3-08 in sterile water, e) 1% Triton X-100
sterile water, f) 10% Na-sarcosylate in sterile water, g) RIPA-buffer
(0.25% Na-deoxycholate, 0.9% NaCl, 1% NOP-40, 0.8% Tris-HCl
in sterile water (Carl Roth GmbH, Karlsruhe, Germany), h) 10%
NOP-40 in sterile water, (Sigma-Aldrich, Steinheim, Germany).
Initially non-infectious pork brain was mixed with German
standard soil and the efficiency of PrP
C extraction using the above
mentioned buffers was tested. In a second step, the optimal
extraction procedure was verified by applying the procedure to soil
samples mixed with 263K scrapie agent and monitoring the PrP
Sc
retrieval.
Incubation Experiments and Sampling Scheme
The outdoor experiments and all other experiments were
performed using brains of terminally-diseased hamsters challenged
with scrapie strain 263K.
For each approach, 1 g infectious hamster brain material was
homogenized in 10 ml PBS (phosphate buffered saline) and added
to 20 g of standard German sandy loom soil (Borstel). The soil/
brain mixture was filled into gauze bags and buried in lysimeters
filled with the same soil at a depth between 15 and 20 cm. The
gauze had a mesh size of 250 mm, which enables the contact with
microorganisms and meso fauna with the soil/brain mixture but
avoids the contact with macro fauna derived/related organisms.
To protect the gauze bags from mice, the bags were put into steel
cages. At defined time points (after 0, 1, 3, 6, 12, 18, 21, 26,
29 months) the steel cages were dug out and the gauze bags as well
as the surrounding soil were taken for sampling and analyzing.
The analyses on the presence of residual PrP27-30 in soil samples
were performed with a different number of soil bags, depending on
the incubation times to be tested. For ‘‘short’’ incubation times of
,12 months, for which detectability of residual PrP appeared
most likely when the experiments were designed, samples from
three different soil bags were examined. For ‘‘intermediate’’
incubation times of 12–18 months samples from two different bags
were tested, and for ‘‘long’’ incubation times of .18 months one
soil bag was yet available for sampling. All bags were buried in
close vicinity.
Sample Preparation and Western Blot Analysis of
Soil and Hamster Brain Samples
Remark: Western blot experiments were performed in
independent runs at different laboratories, with each laboratory
using its established techniques and procedures. The protocols are
listed below. The different analytical protocols produced consistent
results.
Western Protocol I
For the protein extraction from the contaminated soil as well as
from surrounding soil samples, 20 ml of a 1%-SDS-solution (SDS;
Sigma-Aldrich, Steinheim, Germany) were added to 20 g of
testing material in a 50 ml tube. The suspension was vigorously
shaken on a horizontal shaker for approx. 1 h, followed by
a centrifugation step at 5,000 rpm for 20 min. 200 ml of the clear
supernatant was incubated with proteinase K (50 mg/ml; 37uC;
1 h, Carl Roth GmbH, Karlsruhe, Germany) to eliminate non-
resistant proteins. After digestion, the supernatants were boiled for
5 min in Laemmli’s sampling buffer (50 mM Tris (pH 6.8), 2%
SDS, 10% glycerol, 50 mM ß-mercaptoethanol and 0.001%
bromphenol blue) in a 1.5 ml tube and analyzed by Western
blotting. The prepared samples were stored at 280uC.
For screening, Western blot samples were boiled for 5 min and
separated by polyacrylamide gel electrophoresis (SDS-PAGE) by
using 8–16% Tris-Glycine-SDS precast gels (i-Gels, Gradipore,
LTF-Labortechnik, Wasserburg, Germany) or 4–20% precast gels
(Precise Protein Gels, Perbio Science GmbH, Heidelberg,
Germany) according to standard procedures as described pre-
viously [55–57]. After SDS-PAGE, the proteins were transferred
to a polyvinylidene difluoride membrane (PVDF, Immobilon
Millipore, Billerica, USA) using a semi-dry blotting system.
Membranes were blocked in Superblock (Perbio Science GmbH,
Heidelberg, Germany) with 0.05% Tween 20 over night at 4uC.
Blots were incubated for 1 h in primary antibody solution
(monoclonal anti-PrP 3F4, Chemicon International, Inc., Califor-
nia, dilution: 1:3,000 in PBS and 1.5% BSA or monoclonal anti-
PrPSc and Prion Infectivity
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PBS and 1.5% BSA or monoclonal anti-mouse 6H4, Prionics AG,
Zu ¨rich, Switzerland, 1:3,000 in PBS). After washing 5 times with
PBS for 5 min and 0.05% Tween 20 (Perbio Science GmbH,
Heidelberg, Germany), blots were incubated in a secondary
antibody solution (horseradish peroxidase-conjugated anti-mouse,
dilution 1:500,000 Perbio Science GmbH or alkaline-phosphatase-
conjugated anti-mouse, dilution 1:5,000 Sigma-Aldrich, Stein-
heim, Germany) for at least 1.5 h. Membranes were washed as
described before and developed with CDP-Star solution (Invitro-
gen GmbH, Karlsruhe, Germany) or SuperSignal West Femto
Maximum Sensitivity substrate (Perbio Science GmbH, Heidel-
berg, Germany) for 5 to 10 min. Protein signals were visualized
using Pierce film (Perbio Science GmbH, Heidelberg, Germany).
For confirmation of these results, highly sensitive Western
blotting was performed in independent experiments at different
laboratories using their established protocols.
Western Protocol II
The protein extractions from contaminated soil samples were
carried out by adding 2 ml 1%-SDS-solution to 2 g of testing
material in a 15 ml tube. The suspension was vigorously shaken
for 2 min, followed by a centrifugation step at 7,000 rpm for
10 min. 50 ml of the clear supernatant was used for proteinase K
digestion (100 mg/ml; 37uC; 1 h). After digestion the supernatants
were mixed with an equal volume of 26 sample loading buffer
(50 mM Tris (pH 6.8), 2% SDS, 10% glycerol, 50 mM ß-
mercaptoethanol and 0.001% bromphenol blue) and heated to
100uC for 5 min for PrP-Western blotting.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot analyzes of samples from hamsters
were performed as described elsewhere [58] with recently
published modifications [39]. In short: Following SDS-PAGE,
proteins were transferred to a polyvinylidene difluoride (PVDF)
membrane (Immobilon, Millipore, Billerica, USA) using a semi-
dry blotting system. The membrane was blocked by incubation for
30 min in TBS containing 3% (w/v) nonfat milk powder (NFMP)
and 0.05% (w/v) Tween-20 (NFMP-TBST). Blots were incubated
overnight in primary antibody solution (monoclonal anti-PrP
antibody 3F4 [mAb 3F4] from cell culture, diluted 1:2,000 in
NFMP-TBST) at 4uC. After washing 5 times for at least 20 min
with NFMP-TBST, blots were incubated in secondary antibody
solution (alkaline phosphatase conjugated goat anti-mouse IgG;
Dako, Glostrup, Denmark; 1:5,000 diluted in NFMP-TBST) for
90 min at room temperature. After washing 5 times with NFMP-
TBST over a total period of at least 1.5 h, the membranes were
pre-incubated 265 min in assay-buffer (100 mM Tris, 100 mM
NaCl, pH 9.5) and finally developed with CDP-star solution
(Tropics, Applied Biosystems, Beford, USA) for 5 min according
to the instructions of the manufacturer. PrP-signals were visualized
on a X-OMAT AR (Kodak, Sigma-Aldrich, Steinheim, Germany)
film. Films were exposed for 5–30 min.
For deglycosylation, 500 ml of the soil extract solution were
dialyzed in PBS for 16 h in order to remove the detergents, and
20 ml of the aliquot was digested using PNGase F (New England
Biolabs, Ipswich, USA) according to the instructions of the
manufacturer prior to Western blotting.
Western Protocol III
Sample preparation and extraction of the prion protein from soil
samples as well as proteinase K digestion was performed as
described in protocol I. After electrophoresis using 16% bis-
acrylamide gels, proteins were transferred on a PVDF-membrane
in a semi-dry chamber. The membranes were blocked in 5% dry
fat milk in PBS (phosphate buffered saline) containing 0.1%
Tween 20 (Merck, Darmstadt, Germany) (PBS-T) for 30 min and
subsequently incubated with the PrP-specific monoclonal detection
antibody 3F4 (Chemicon International, Inc., California) in
a dilution of 1:3,000 in 5% dry fat milk in PBS-T for 1 h
30 min. The membranes were washed 3 times for 10 min with
PBS-T and then incubated with a secondary antibody bound to
alkaline phosphatase in a dilution of 1:2,000 in PBS-T (goat-anti-
mouse-AP, Dianova, Hamburg, Germany) for 1 h. After again
washing three times for 10 min, the membranes were incubated 2
times for 2 min in assay buffer containing 200 mM Tris-HCl and
10 mM MgCl2 (pH 9.8). Finally, the chemiluminescence substrate
CDP-Star (Tropix, Bedford, USA) was applied and incubated on
the membrane for 5 min before the light signals were detected in
a camera using the analysis software Quantity One (Bio-Rad,
Munich, Germany).
Bioassay in Syrian hamsters
Forty two female Syrian hamsters, approx. 90 days old, were
obtained from Charles River Laboratories, Germany. They were
handled according to the regulations of the local authorities
(Bezirksregierung Arnsberg, reference number 50.8735.1 Nr. 108/
1) in a biosafety Level 3 containment facility.
12 animals were fed weekly over a period of 12 weeks; 11 times
with 100 mg soil/brain mixture each and one time with 50 mg
soil/brain mixture taken from the outdoor lysimeters after an
incubation period of 26 and 29 months (table 1). Oral application
was achieved by mixing the soil (1,150 mg in total) with
commercial hamster feed (ssniff, Soest, Germany).
To analyze the remaining infectivity in the aqueous extract,
10 g contaminated soil was mixed with 10 ml water and was
vigorously shaken on a horizontal shaker for approx. 1 h. The
mixture was centrifuged with 5,000 rpm for 5 min and the
supernatant was used for the bioassay. Oral application was
performed weekly over a period of 12 weeks (1,150 ml in total) by
mixing the extract with commercial hamster feed (ssniff, Soest,
Germany). For this purpose, 12 additional animals were fed 11
times with 100 ml and 1 time with 50 ml aqueous extract from the
soil/brain mixture taken from the outdoor lysimeters after an
incubation period of 26 and 29 months.
The hamsters of both groups were monitored at least twice
a week for the development of clinical signs of scrapie. Hamsters
diseased with 263K scrapie showed head bobbing, ataxia of gait
and generalized tremor. Such animals were frequently and
persistently in motion, easily irritated by noise and touch, upon
which they often twitch, and had difficulties maintaining balance
and rising from a supine position. These clinical symptoms of
hamsters are entirely consistent with those previously reported for
the 263K scrapie agent [59]. At the occurrence of first
neurological symptoms, the animals were observed daily and at
appropriate end-points, clinically affected hamsters were killed.
Brains from these hamsters were examined and analyzed for the
presence of PrP
Sc.
As a control, six animals were fed with non-contaminated
standard soil and 6 animals were fed with aqueous extract from
non-contaminated standard soil over a period of 12 weeks
(1,150 mg or 1,150 ml in total). Additional 6 hamsters were fed
only with commercial hamster feed (ssniff, Soest, Germany).
PMCA-Reaction
The PMCA method was carried out as reported previously [45,46]
with modifications: In brief, normal hamster brains were
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inhibitor cocktail (Boehringer-Ingelheim, Mannheim, Germany),
4 mM EDTA and 1% Triton-X-100. The homogenate was briefly
centrifuged at 2,000 g and the supernatant was used as the PrP
C
source. Amplification was performed using an automatic ultra-
sonification apparatus (Sonicator 300 from Misonix, New York,
USA) with a water-tank.
The PrP
C substrate was mixed with 1/10 volume of the soil
extract previously dialyzed in PBS, resulting in a total volume of
100 ml. PMCA amplification was performed by 40 cycles of
sonication (40 sec. each) followed by incubation at 37uC for 1 h in
the water-tank. The amplified product of the first round of
amplification was diluted 1:5 with normal brain homogenate and
the second round was performed. This process was repeated 4
times to obtain 160 cycles of PMCA. From each PMCA-
amplification round, aliquots of 50 ml were taken and digested
with proteinase K (180 mg/ml) for 1 h at 56uC. Finally, the same
volume of 26sample buffer was added and heated for 10 min at
100uC prior to SDS-PAGE.
Western Blot Typing of PrP27-30
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blot analyzes of samples from hamsters for
characterization of the PrP
Sc glycosylation and migration pattern
were performed as described elsewhere [59]. In short: 50 mlo f
10% (w/v) brain homogenates in TBS (pH 7.4) were mixed with
5 ml of 13% (w/v) sarcosyl and 10 ml proteinase K stock solution
(1 mg/ml; Roche, Mannheim, Germany) and digested for 60 min
at 37uC. The digestion was stopped by adding 435 ml2 6sample
buffer, i.e. 4% (w/v) SDS, 10% (v/v) 2-mercaptoethanol in
120 mM Tris-HCl, pH 6.8, containing 20% (w/v) glycerol and
0.05% (w/v) bromophenol blue, and boiling for 5 min. 5 ml of the
solution (corresponding to 5610
25 grams of homogenized brain
tissue) were separated in a 15% SDS-PAGE or in Tris-glycine gels
(Novex, Invitrogen, Carlsbad, USA) and subsequently blotted onto
polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica,
USA) using the semi-dry method (Fast-Blot; Biometra, Go ¨ttingen,
Germany). The PVDF-membranes were blocked with 5% low-fat
milk in TBS for 30 min and incubated overnight at 4uC with MAb
3F4 (1:2,000) in 3% bovine serum albumin (BSA) in TBS. After
washing in TBS and incubation for 60 min at room temperature
with the secondary antibody [biotinylated goat anti-mouse IgG
(1:2,000) in 3% BSA in TBS], a biotin-streptavidin kit (Dako,
Glostrup, Denmark) for signal enhancement was applied for
30 min at room temperature. After washing the membranes in
TBS, antibody binding to PrP was visualized using a mixture of
nitroblue-tetrazoleum (NBT; Sigma-Aldrich, Steinheim, Ger-
many) and 5-bromo-4-chloro-3-indolylphosphate (BCIP; Sigma-
Aldrich, Steinheim, Germany) as substrate.
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